HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Penna, G. Articles by Adorini, L. Search for Related Content PubMed PubMed Citation Articles by Penna, G. Articles by Adorini, L.

Cutting Edge: Selective Usage of Chemokine Receptors by Plasmacytoid Dendritic Cells¹

Giuseppe Penna^*, Silvano Sozzani and Luciano Adorini^2,*

^* Roche Milano Ricerche, Milan, Italy; and Istituto Ricerche Farmacologiche "Mario Negri," Milan, Italy

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
The existence of dendritic cell (DC) subsets is firmly established, but their trafficking properties are virtually unknown. In this study, we show that myeloid (M-DCs) and plasmacytoid (P-DCs) DCs isolated from human blood differ widely in the capacity to migrate to chemotactic stimuli. The pattern of chemokine receptors expressed by blood M-DCs and P-DCs, with the exception of CCR7, is similar. However, most chemokine receptors of P-DCs, in particular those specific for inflammatory chemokines and classical chemotactic agonists, are not functional in circulating cells. Following maturation induced by CD40 ligation, the receptors for inflammatory chemokines are down-regulated, and CCR7 on P-DCs becomes coupled to migration. The drastically impaired capacity of blood P-DCs to migrate in response to inflammatory chemotactic signals contrasts with the response to lymph node-homing chemokines, indicating a propensity to migrate to secondary lymphoid organs rather than to sites of inflammation.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Dendritic cells (DCs),³ a highly specialized APC system critical for the initiation of CD4⁺ T cell responses, are present, in different stages of maturation, in the circulation as well as in lymphoid and nonlymphoid organs (1). DCs are heterogeneous in terms of origin, morphology, phenotype, and function (2, 3). In the mouse thymus, two distinct subsets have been identified based on CD8 expression (4). CD8⁺ DCs seem to derive from an early thymic lymphoid precursor, suggesting a lymphoid origin, whereas CD8^- DCs appear to be of myeloid origin (5). The existence of mouse DC subsets prompted the search for similar subpopulations in humans. Two distinct DC subsets were originally defined in the human blood based on the expression of CD11c (6). More recent work has characterized these two subsets as belonging to the myeloid or lymphoid lineage and, although different denominations have been used, they can be defined as myeloid DCs (M-DCs) and plasmacytoid DCs (P-DCs) (7). M-DCs are characterized by a monocytic morphology, express myeloid markers like CD13 and CD33, the ₂ integrin CD11c, the inhibitory receptor Tg-like transcript 1 (ILT1) and low levels of the IL-3R -chain CD123 (8). Conversely, P-DCs have a morphology resembling plasma cells, are devoid of myeloid markers, and express high levels of CD4, CD62 ligand (L), and CD123 (9, 10). M-DCs produce high levels of IL-12 (11), whereas P-DCs produce high levels of IFN- (10, 12). Based on their capacity to induce, under appropriate conditions, predominantly Th1 or Th2 cells, human M-DCs and P-DCs have also been designated as DC1 and DC2 (11). In vivo studies indicate that P-DCs, in normal conditions, are preferentially localized in secondary lymphoid tissues, but their location in inflammatory conditions is still unclear (8, 10, 13).

The proper localization of DCs in secondary lymphoid organs and their recruitment at sites of inflammation in response to chemotactic stimuli are critical for an optimal immune response. In this study, we report that, despite a similar expression and modulation of chemokine receptors, circulating P-DCs, in contrast to M-DCs, fail to migrate in response to inflammatory chemokines, whereas both subsets respond to lymph node-homing chemokines following CD40 ligation. These different migration programs underscore the distinct lineage of these DC subsets and point to their distinct roles in the induction and regulation of the immune response.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Peripheral blood DC purification

PBMC were isolated from buffy coats by Ficoll gradient (Pharmacia Biotech, Uppsala, Sweden) and peripheral blood DCs were purified with a blood DC cell isolation kit (Miltenyi Biotec, Bergish Gladblach, Germany) to a purity of 80–90%. Purified blood DCs were stained with Lin 1-FITC and HLA-DR PerCP, followed by CD123-PE or CD11c-PE and sorted with a FACSVantage (BD Biosciences, Mountain View, CA). Alternatively, blood M-DCs and P-DCs were magnetically sorted with BDCA-1 and BDCA-4 cell isolation kits (Miltenyi Biotec) (14), respectively, to a purity of 90–98% in both cases.

Flow cytometric analysis

Flow cytometric analysis was performed as previously described (15) in the presence of 100 µg/ml mouse IgG using the following mAbs from BD PharMingen (San Diego, CA): anti-lineage mixture 1 (containing mAbs specific for CD3, CD14, CD16, CD19, CD20, and CD56) FITC, anti-HLA-DR Cy/PerCP, anti-CD123-PE, anti-CD11c-PE, anti-CD62L-FITC, anti-CD36-FITC, anti-CD45RA-FITC, anti-CCR4, anti-CCR5-PE, anti-CCR7, anti-CXCR1-PE, anti-CXCR2-PE, and anti-CXCR5-PE. Anti-CCR1-PE, anti-CCR2-PE, anti-CCR6-PE, anti-CXCR3-FITC, and anti-CXCR4-FITC were purchased from R&D Systems (Minneapolis, MN). The anti-ILT1 mAb, a kind gift from Dr. M. Colonna (Basel Institute of Immunology, Basel, Switzerland), has been described previously (16). The anti-CCR3 mAb was a kind gift from Dr. C. McKay (Millennium Pharmaceuticals, Cambridge, MA). The fMLP receptor was revealed using fMLP-FITC (Molecular Probes, Eugene, OR). Cells were analyzed with a FACScan flow cytometer using CellQuest software (BD Biosciences).

Chemotaxis assay

DC subset migration was measured by chemotaxis through a 5-µm pore polycarbonate filter in 24-well transwell chambers (Corning, Cambridge, MA). Enriched blood DCs were stained to distinguish Lin1^-HLA-DR⁺CD11c⁺ cells (M-DCs) and Lin1^-HLA-DR⁺CD11c^- cells (P-DCs). Alternatively, sorted DC subsets were used, as specified in the text. Serial dilutions of chemokines were added to the lower wells and 10⁵ cells to the transwell insert. The following chemokines were used: RANTES, stromal-derived factor 1 (SDF-1), eotaxin, macrophage-derived chemokine, I-309, IFN-inducible T cell chemoattractant (I-TAC), pulmonary and activation-regulated chemokine (Dictagene, Geneva, Switzerland), monocyte chemoattractant protein 1 (MCP-1) (BD PharMingen), macrophage inflammatory protein 3 (MIP-3), secondary lymphoid tissue chemokine, thymus-expressed chemokine, IFN--inducible protein of 10 kDa (IP-10), monokine induced by IFN- (Mig), B lymphocyte chemokine, and IL-8 (R&D Systems). In addition, the chemotactic stimuli platelet-activating factor (PAF) and fMLP (Sigma, St. Louis, MO) were used. After incubation for 90 min at 37°C, the migrated cells were analyzed with a FACScan flow cytometer using CellQuest software (BD Biosciences). The number of cells in the starting population and the migrated population was calculated for each phenotype, and the percent migration was determined from these values. Each experiment was performed in triplicate.

Intracellular calcium fluxes

Magnetically sorted M-DCs and P-DCs (10⁶ cells/ml) were loaded with 4 µM fluo-3-acetoxymethyl ester in the presence of 1 µM pluronic F-127 (Molecular Probes) in HBSS containing 5% FCS for 30 min at 37°C. Cells were washed twice, incubated with the indicated chemokine concentrations or with 1 µg/ml ionomycin, and analyzed with a FACScan.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Similar chemokine receptor expression but distinct migration patterns of blood M-DCs and P-DCs

Enriched peripheral blood DCs (Lin^- CD4⁺) from healthy donors were sorted based on the expression of CD123. Two discrete populations, both HLA-DR⁺, were obtained, expressing high and low levels of CD123 (Fig. 1A). The CD123^low cells expressed the ILT1 (16), whereas the CD123^high were ILT1^-. Based on the previously described subsets of blood DCs (10), the CD123^lowILT1⁺ cells correspond to M-DCs and the CD123^highILT1^- cells to P-DCs. Additional phenotypic analysis of the sorted populations demonstrated that M-DCs were CD11c⁺, CD62L^low, CD36^low, and CD45RA^low, whereas P-DCs were CD11c^-, CD62L^high, CD36^high, and CD45RA^high (data not shown), confirming the subset assignment (10).

View larger version (66K): [in this window] [in a new window]   FIGURE 1. Similar chemokine receptor expression in blood DC subsets. A, Phenotype of M-DCs and P-DCs sorted for CD123 expression from Lin-1-HLA-DR+ human PBMC. ILT1 is selectively expressed on M-DCs. Isotype controls are in gray. B, Chemokine receptor expression analyzed on sorted M-DCs and P-DCs directly after isolation. Isotype controls are shown in gray. Results are from a representative experiment of two to five performed.

In contrast with the overall similar pattern of chemokine receptor expression, with the exception of CCR7, circulating M-DCs and P-DCs exhibited a profoundly different migration capacity in response to chemokines (Fig. 2). A relatively high proportion of M-DCs migrated in response to RANTES, renamed CCL5 (17), MCP-1/CCL2, and SDF-1/CXCL12, whereas a lower proportion migrated in response to eotaxin/CCL11, MIP-3/CCL20, IP-10/CXCL10, I-TAC/CXCL11, and Mig/CXCL9. No significant migration was seen in response to MDC/CC chemokine ligand (CCL)22, thymus and activation-regulated chemokine/CCL17, EBI 1 ligand chemokine (ELC)/CCL19, I-309/CCL1, thymus-expressed chemokine/CCL25, B lymphocyte chemokine/CXCL13, and IL-8/CXCL8. Conversely, P-DCs migrated only in response to SDF-1, the ligand of CXCR4. SDF-1 has previously been reported to induce migration of both P-DCs and M-DCs (18). The migration of P-DCs to SDF-1, although lower than M-DCs, was substantial (percentage of migrated cells 6.4 ± 1.6 vs 33.2 ± 3.6, n = 9). The migration index to SDF-1 was 249 ± 52 for P-DCs and 42 ± 9 for M-DCs, arguing against a generalized migration defect in P-DCs. Intriguingly, in addition to CXCR4, P-DCs expressed CCR7 and CXCR3, but did not migrate in response to any of the ligands of these two receptors, except for a negligible migration (<2% of input cells) to the highest dose of ELC tested (1 µg/ml). Similarly, the high expression of CCR2 and CCR5 by P-DCs was not paralleled by migration in response to MCP-1 or RANTES. Thus, although blood P-DCs can migrate in response to chemokines, as shown by the chemotactic response to SDF-1, it appears that most of the chemokine receptors expressed by this DC subset are not functional. This conclusion is also supported by the fact that a calcium flux was observed following stimulation of P-DCs with SDF-1 but not IP-10 nor RANTES, indicating a proximal defect in ligand signaling via CXCR3 and CCR5, respectively (Fig. 3).

View larger version (36K): [in this window] [in a new window]   FIGURE 2. Migration of blood M-DCs and P-DCs to chemotactic stimuli. Enriched blood DCs were stained to allow the identification of M-DCs and P-DCs, and their migration (105 input cells/well) to different concentrations of chemotactic stimuli was measured. The average absolute numbers of M-DC and P-DC input cells/well were 16 ± 7 and 47 ± 18 x 103. Results are expressed as mean percent migration of input cells ± SE from triplicate wells. Representative experiments of three to five performed are shown.

View larger version (70K): [in this window] [in a new window]   FIGURE 3. Intracellular calcium fluxes induced by chemokines in P-DCs. Calcium fluxes were measured as described in Materials and Methods in the presence of ionomycin (1 µg/ml), RANTES (100 ng/ml), IP-10 (500 and 1000 ng/ml), and SDF-1 (100 and 500 ng/ml).

Modulation of responsiveness to chemokines in mature M-DCs and P-DCs

Signals that induce DC maturation affect also their capacity to migrate in response to chemotactic signals (19, 20, 21). We have examined the migration to chemokines and the expression of chemokine receptors in M-DCs and P-DCs ex vivo and after maturation induced by CD40 ligation, as shown by CD83 expression (Fig. 4). Culture of M-DCs and P-DCs with CD40L-expressing cells abrogated the capacity of freshly isolated M-DCs to migrate to RANTES and IP-10, while up-regulating the capacity to migrate in response to ELC and maintaining responsiveness to SDF-1, despite undetectable CXCR4 expression. As with circulating M-DCs, the expression of chemokine receptors in cells matured in vitro paralleled their capacity to migrate in response to chemokines. In contrast, P-DCs cultured for 2 day in IL-3 and stimulated by CD40 ligation lost the capacity to respond to SDF-1, the only chemotactic signal tested active on blood P-DCs, but acquired the capacity to migrate in response to ELC.

View larger version (42K): [in this window] [in a new window]   FIGURE 4. Coupling of CCR7 in mature P-DCs. Magnetically purified M-DCs and P-DCs (5 x 104 cells/well) were analyzed for migration to the indicated chemokines (100 ng/ml for RANTES and SDF-1, 500 ng/ml for ELC and IP-10) and expression of chemokine receptors directly after isolation or after 48 h culture with GM-CSF/IL-4 or IL-3, respectively, in the presence of CD40L. Migration is expressed as in Fig. 2. Chemokine receptor expression is shown as geometric mean fluorescence intensity (MFI), with isotype control subtracted. CD83 expression was simultaneously analyzed and isotype controls are shown in gray. Results are from a representative experiment of two to four performed.

In both subsets, the modulation of chemokine receptor expression upon maturation followed the pattern exhibited by monocyte-derived DCs, with down-regulation of CCR5, CXCR3, and CXCR4 and strong up-regulation of CCR7 (19). Thus, the expression of chemokine receptors not functional in blood P-DCs, like CCR5, CCR7, and CXCR3, is modulated similarly to their functional counterparts expressed by M-DCs.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
Our results show that M-DCs and P-DCs circulating in the human blood have distinct migration patterns. Although M-DCs could migrate in response to several constitutive and inducible chemokines, freshly isolated P-DCs showed responsiveness only to SDF-1. Despite their divergent capacity to migrate, P-DCs and M-DCs expressed a comparable repertoire of adhesion molecules (e.g., CD50, CD58, CD62L, CLA; data not shown), and chemokine receptors that were, however, not functional in P-DCs.

P-DCs are found in lymph nodes where they have migrated from the blood via the high endothelial venules (13), but this does not appear to be mediated by responsiveness to IP-10, Mig, or I-TAC, the ligands of CXCR3. Indeed, blood P-DCs fail to migrate in response to these chemokines, although this was inferred by their expression of CXCR3 (10). Rather P-DCs may reach lymph nodes, independently of inflammatory stimuli (8), using CXCR4, the receptor of SDF-1, a chemokine expressed within the lymph node (22), and CD62L that interacts with L-selectin ligands expressed by high endothelial venules (23). This interaction may provide a maturation signal (24) that couples CCR7 with migration, allowing proper positioning of P-DCs in the T cell areas of secondary lymphoid tissues in response to secondary lymphoid tissue chemokine and ELC. A comparative analysis of migration and chemokine receptor expression in blood and tonsil or lymph node P-DCs is ongoing to further clarify this issue.

The uncoupling of chemokine receptor expression and migration has been reported in other cell types. Germinal center B lymphocytes express CXCR4 but do not migrate to SDF-1 (25), and circulating B cells do not respond to MIP-3 despite the surface expression of CCR6 (26). Furthermore, the expression of nonfunctional IL-8 receptors has been described in human monocytes (27) and monocyte-derived DCs (28). Finally, uncoupled chemokine receptors induced by IL-10 in LPS-stimulated monocyte-derived DCs have been proposed to generate functional decoy receptors that act as molecular sinks and scavengers for inflammatory chemokines (29). Although blood P-DCs constitute a sparse population that may not accumulate at sites where these ligands are active, it is possible that the membrane expression of nonfunctional chemokine receptors by P-DCs may influence the trafficking properties of activated cells and contribute to the regulation of the immune response.

During maturation of human monocyte-derived DCs, the expression of CCR1, CCR2, CCR5, CCR6, and CXCR1 is down-regulated with increased expression of CCR7 (19, 20, 30). This "switch paradigm" seems to hold also for M-DCs and P-DCs. However, blood P-DCs already express high membrane levels of CCR7, and this expression is further increased during maturation. Intriguingly, maturation allows coupling of CCR7 to cell migration in P-DCs. This is associated with down-regulation of receptors for inflammatory chemokines, indicating that also mature P-DCs fail to respond to inflammatory chemotactic stimuli. In addition to maturation, it is possible that other signals, for example, via Toll receptors (31) or virus infection (32), may allow rapid coupling of migration with chemokine receptor expression. This may endow P-DCs with the capacity to migrate to sites of inflammation, as shown by their dramatic increase in the nasal mucosa during the allergic reaction (33). Migration of M-DCs and P-DCs to SDF-1 is also differently regulated by maturation, being maintained in the former and lost in the latter cell subset. Therefore, M-DCs and P-DCs present a different regulation of their migration profile, both at the immature and mature stage.

In conclusion, the different migration programs of blood M-DCs and P-DCs, and the expression by P-DCs of nonfunctional chemokine receptors point to a primary involvement of M-DCs in inflammation and of P-DCs in the homeostatic control of the immune response. This would be consistent with the capacity of P-DCs not only to induce Th1 (34) but also Th2 (11) and possibly T regulatory (35) cells.

	Acknowledgments

 
We thank Drs. D. D’Ambrosio, A. Mantovani, and P. Panina for critical reading of this manuscript.

	Footnotes

 
¹ This work was supported in part by European Community Grants QLRT-1999-00276 (to S.S.) and QLRT-2000-02103 (to L.A.).

² Address correspondence and reprint requests to Dr. Luciano Adorini, Roche Milano Ricerche, Via Olgettina 58, I-20132 Milan, Italy. E-mail address: Luciano.Adorini{at}roche.com

³ Abbreviations used in this paper: DC, dendritic cell; M-DC, myeloid DC; P-DC, plasmacytoid DC; L, ligand; MCP-1, monocyte chemoattractant protein 1; MIP-1, macrophage inflammatory protein 1; IP-10, inflammatory protein 10; PAF, platelet-activating factor; ILT1, Ig-like transcription factor 1; SDF-1, stromal-derived factor 1; I-TAC, IFN-inducible T cell chemoattractant; PARC, pulmonary and activation-regulated chemokine; Mig, monokine induced by IFN-; CCL, CC chemokine ligand; ELC, EBI 1 ligand chemokine.

Received for publication April 13, 2001. Accepted for publication June 21, 2001.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Banchereau, J., R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.[Medline]
2. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.[Medline]
3. Reid, S. D., G. Penna, L. Adorini. 2000. The control of T cell responses by dendritic cell subsets. Curr. Opin. Immunol. 12:114.[Medline]
4. Vremec, D., M. Zorbas, R. Scollay, D. J. Saunders, C. F. Ardavin, L. Wu, K. Shortman. 1992. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176:47.[Abstract/Free Full Text]
5. Shortman, K., L. Wu. 1996. Early T lymphocyte progenitors. Annu. Rev. Immunol. 14:29.[Medline]
6. O’Doherty, U., M. Peng, S. Gezelter, W. J. Swiggard, M. Betjes, N. Bhardwaj, R. M. Steinman. 1994. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82:487.[Medline]
7. Banchereau, J., B. Pulendran, R. Steinman, K. Palucka. 2000. Will the making of plasmacytoid dendritic cells in vitro help unravel their mysteries?. J. Exp. Med. 192:39.
8. Olweus, J., A. BitMansour, R. Warnke, P. A. Thompson, J. Carballido, L. J. Picker, F. Lund-Johansen. 1997. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc. Natl. Acad. Sci. USA 94:12551.[Abstract/Free Full Text]
9. Grouard, G., M. C. Rissoan, L. Filgueira, I. Durand, J. Banchereau, Y. J. Liu. 1997. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185:1101.[Abstract/Free Full Text]
10. Cella, M., D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, A. Lanzavecchia, M. Colonna. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:919.[Medline]
11. Rissoan, M. C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. de Waal Malefyt, Y. J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183.[Abstract/Free Full Text]
12. Siegal, F. P., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284:1835.[Abstract/Free Full Text]
13. Facchetti, F., C. De Wolf-Peeters, J. J. van den Oord, R. De vos, V. J. Desmet. 1988. Plasmacytoid T cells: a cell population normally present in the reactive lymph node. An immunohistochemical and electron microscopic study. Hum. Pathol. 19:1085.[Medline]
14. Dzionek, A., A. Fuchs, P. Schmidt, S. Cremer, M. Zysk, S. Miltenyi, D. W. Buck, J. Schmitz. 2000. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165:6037.[Abstract/Free Full Text]
15. Penna, G., L. Adorini. 2000. 1,25-dihydroxyvitamin D₃ inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164:2405.[Abstract/Free Full Text]
16. Nakajima, H., J. Samaridis, L. Angman, M. Colonna. 1999. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor -chain. J. Immunol. 162:5.[Abstract/Free Full Text]
17. Zlotnik, A., O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121.[Medline]
18. Dieu-Nosjean, M. C., C. Massacrier, B. Homey, B. Vanbervliet, J. J. Pin, A. Vicari, S. Lebecque, C. Dezutter-Dambuyant, D. Schmitt, A. Zlotnik, C. Caux. 2000. Macrophage inflammatory protein 3 is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 192:705.[Abstract/Free Full Text]
19. Sozzani, S., P. Allavena, G. D’Amico, W. Luini, G. Bianchi, M. Kataura, T. Imai, O. Yoshie, R. Bonecchi, A. Mantovani. 1998. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161:1083.[Abstract/Free Full Text]
20. Dieu, M. C., B. Vanbervliet, A. Vicari, J. M. Bridon, E. Oldham, S. Ait-Yahia, F. Briere, A. Zlotnik, S. Lebecque, C. Caux. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188:373.[Abstract/Free Full Text]
21. Lin, C. L., R. M. Suri, R. A. Rahdon, J. M. Austyn, J. A. Roake. 1998. Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation. Eur. J. Immunol. 28:4114.[Medline]
22. Muller, A., B. Homey, H. Soto, N. Ge, D. Catron, M. E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S. N. Wagner, et al 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50.[Medline]
23. Gretz, J. E., C. C. Norbury, A. O. Anderson, A. E. Proudfoot, S. Shaw. 2000. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med. 192:1425.[Abstract/Free Full Text]
24. Randolph, G. J., K. Inaba, D. F. Robbiani, R. M. Steinman, W. A. Muller. 1999. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11:753.[Medline]
25. Bleul, C. C., J. L. Schultze, T. A. Springer. 1998. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J. Exp. Med. 187:753.[Abstract/Free Full Text]
26. Liao, F., R. L. Rabin, C. S. Smith, G. Sharma, T. B. Nutman, J. M. Farber. 1999. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3. J. Immunol. 162:186.[Abstract/Free Full Text]
27. Bonecchi, R., F. Facchetti, S. Dusi, W. Luini, D. Lissandrini, M. Simmelink, M. Locati, S. Bernasconi, P. Allavena, E. Brandt, et al 2000. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J. Immunol. 164:3862.[Abstract/Free Full Text]
28. Sozzani, S., W. Luini, A. Borsatti, N. Polentarutti, D. Zhou, L. Piemonti, G. D’Amico, C. A. Power, T. N. Wells, M. Gobbi, et al 1997. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J. Immunol. 159:1993.[Abstract]
29. D’Amico, G., G. Frascaroli, G. Bianchi, P. Transidico, A. Doni, A. Vecchi, S. Sozzani, P. Allavena, A. Mantovani. 2000. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat. Immunol. 1:387.[Medline]
30. Sallusto, F., P. Schaerli, P. Loetscher, C. Schaniel, D. Lenig, C. R. Mackay, S. Qin, A. Lanzavecchia. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28:2760.[Medline]
31. Thoma-Uszynski, S., S. M. Kiertscher, M. T. Ochoa, D. A. Bouis, M. V. Norgard, K. Miyake, P. J. Godowski, M. D. Roth, R. L. Modlin. 2000. Activation of Toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J. Immunol. 165:3804.[Abstract/Free Full Text]
32. Kadowaki, N., S. Antonenko, J. Y. Lau, Y. J. Liu. 2000. Natural interferon /-producing cells link innate and adaptive immunity. J. Exp. Med. 192:219.[Abstract/Free Full Text]
33. Jahnsen, F. L., F. Lund-Johansen, J. F. Dunne, L. Farkas, R. Haye, P. Brandtzaeg. 2000. Experimentally induced recruitment of plasmacytoid (CD123^high) dendritic cells in human nasal allergy. J. Immunol. 165:4062.[Abstract/Free Full Text]
34. Cella, M., M. Salio, Y. Sakakibara, H. Langen, I. Julkunen, A. Lanzavecchia. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:821.[Abstract/Free Full Text]
35. Roncarolo, M. G., M. K. Levings, C. Traversari. 2001. Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. 193:F5.[Medline]

This article has been cited by other articles:

				S. Luangsay, V. Wittamer, B. Bondue, O. De Henau, L. Rouger, M. Brait, J.-D. Franssen, P. de Nadai, F. Huaux, and M. Parmentier Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model J. Immunol., November 15, 2009; 183(10): 6489 - 6499. [Abstract] [Full Text] [PDF]

				F. Angelot, E. Seilles, S. Biichle, Y. Berda, B. Gaugler, J. Plumas, L. Chaperot, F. Dignat-George, P. Tiberghien, P. Saas, et al. Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases Haematologica, November 1, 2009; 94(11): 1502 - 1512. [Abstract] [Full Text] [PDF]

				Y. Gao, B. Majchrzak-Kita, E. N. Fish, and J. L. Gommerman Dynamic accumulation of plasmacytoid dendritic cells in lymph nodes is regulated by interferon-{beta} Blood, September 24, 2009; 114(13): 2623 - 2631. [Abstract] [Full Text] [PDF]

				V. R. Cicinnati, J. Kang, G. C. Sotiropoulos, P. Hilgard, A. Frilling, C. E. Broelsch, G. Gerken, and S. Beckebaum Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon J. Gen. Virol., May 1, 2008; 89(5): 1243 - 1253. [Abstract] [Full Text] [PDF]

				F. Pascale, V. Contreras, M. Bonneau, A. Courbet, S. Chilmonczyk, C. Bevilacqua, M. Eparaud, V. Niborski, S. Riffault, A.-M. Balazuc, et al. Plasmacytoid Dendritic Cells Migrate in Afferent Skin Lymph J. Immunol., May 1, 2008; 180(9): 5963 - 5972. [Abstract] [Full Text] [PDF]

				T. Marafioti, J. C. Paterson, E. Ballabio, K. K. Reichard, S. Tedoldi, K. Hollowood, M. Dictor, M.-L. Hansmann, S. A. Pileri, M. J. Dyer, et al. Novel markers of normal and neoplastic human plasmacytoid dendritic cells Blood, April 1, 2008; 111(7): 3778 - 3792. [Abstract] [Full Text] [PDF]

				K. Gotoh, Y. Tanaka, A. Nishikimi, A. Inayoshi, M. Enjoji, R. Takayanagi, T. Sasazuki, and Y. Fukui Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells Blood, March 15, 2008; 111(6): 2973 - 2976. [Abstract] [Full Text] [PDF]

				S. Fiorentini, E. Riboldi, F. Facchetti, M. Avolio, M. Fabbri, G. Tosti, P. D. Becker, C. A. Guzman, S. Sozzani, and A. Caruso HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype PNAS, March 11, 2008; 105(10): 3867 - 3872. [Abstract] [Full Text] [PDF]

				R. A. Linker, N. Kruse, S. Israel, T. Wei, S. Seubert, A. Hombach, B. Holtmann, F. Luhder, R. M. Ransohoff, M. Sendtner, et al. Leukemia Inhibitory Factor Deficiency Modulates the Immune Response and Limits Autoimmune Demyelination: A New Role for Neurotrophic Cytokines in Neuroinflammation J. Immunol., February 15, 2008; 180(4): 2204 - 2213. [Abstract] [Full Text] [PDF]

				M. Rotondi, L. Chiovato, S. Romagnani, M. Serio, and P. Romagnani Role of Chemokines in Endocrine Autoimmune Diseases Endocr. Rev., August 1, 2007; 28(5): 492 - 520. [Abstract] [Full Text] [PDF]

				A. P. Phadke, G. Akangire, S. J. Park, S. A. Lira, and B. Mehrad The Role of CC Chemokine Receptor 6 in Host Defense in a Model of Invasive Pulmonary Aspergillosis Am. J. Respir. Crit. Care Med., June 1, 2007; 175(11): 1165 - 1172. [Abstract] [Full Text] [PDF]

				G. Penna, S. Amuchastegui, N. Giarratana, K. C. Daniel, M. Vulcano, S. Sozzani, and L. Adorini 1,25-Dihydroxyvitamin D3 Selectively Modulates Tolerogenic Properties in Myeloid but Not Plasmacytoid Dendritic Cells J. Immunol., January 1, 2007; 178(1): 145 - 153. [Abstract] [Full Text] [PDF]

				A. Hosmalin and P. Lebon Type I interferon production in HIV-infected patients J. Leukoc. Biol., November 1, 2006; 80(5): 984 - 993. [Abstract] [Full Text] [PDF]

				D. Fabricius, M. S. O'Dorisio, S. Blackwell, and B. Jahrsdorfer Human Plasmacytoid Dendritic Cell Function: Inhibition of IFN-{alpha} Secretion and Modulation of Immune Phenotype by Vasoactive Intestinal Peptide J. Immunol., November 1, 2006; 177(9): 5920 - 5927. [Abstract] [Full Text] [PDF]

				U. Yrlid, V. Cerovic, S. Milling, C. D. Jenkins, J. Zhang, P. R. Crocker, L. S. Klavinskis, and G. G. MacPherson Plasmacytoid Dendritic Cells Do Not Migrate in Intestinal or Hepatic Lymph J. Immunol., November 1, 2006; 177(9): 6115 - 6121. [Abstract] [Full Text] [PDF]

				C. M. Freeman, V. R. Stolberg, B.-C. Chiu, N. W. Lukacs, S. L. Kunkel, and S. W. Chensue CCR4 Participation in Th Type 1 (Mycobacterial) and Th Type 2 (Schistosomal) Anamnestic Pulmonary Granulomatous Responses J. Immunol., September 15, 2006; 177(6): 4149 - 4158. [Abstract] [Full Text] [PDF]

				Y. Hu and L. B. Ivashkiv Costimulation of Chemokine Receptor Signaling by Matrix Metalloproteinase-9 Mediates Enhanced Migration of IFN-{alpha} Dendritic Cells J. Immunol., May 15, 2006; 176(10): 6022 - 6033. [Abstract] [Full Text] [PDF]

				N. Sanchez-Sanchez, L. Riol-Blanco, and J. L. Rodriguez-Fernandez The Multiple Personalities of the Chemokine Receptor CCR7 in Dendritic Cells J. Immunol., May 1, 2006; 176(9): 5153 - 5159. [Abstract] [Full Text] [PDF]

				M. O. Aksoy, Y. Yang, R. Ji, P. J. Reddy, S. Shahabuddin, J. Litvin, T. J. Rogers, and S. G. Kelsen CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L909 - L918. [Abstract] [Full Text] [PDF]

				D. Giordano, D. M. Magaletti, and E. A. Clark Nitric oxide and cGMP protein kinase (cGK) regulate dendritic-cell migration toward the lymph-node-directing chemokine CCL19 Blood, February 15, 2006; 107(4): 1537 - 1545. [Abstract] [Full Text] [PDF]

				G. Penna, A. Roncari, S. Amuchastegui, K. C. Daniel, E. Berti, M. Colonna, and L. Adorini Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3 Blood, November 15, 2005; 106(10): 3490 - 3497. [Abstract] [Full Text] [PDF]

				M. Lindstedt, K. Lundberg, and C. A. K. Borrebaeck Gene Family Clustering Identifies Functionally Associated Subsets of Human In Vivo Blood and Tonsillar Dendritic Cells J. Immunol., October 15, 2005; 175(8): 4839 - 4846. [Abstract] [Full Text] [PDF]

				B. A. Zabel, S. J. Allen, P. Kulig, J. A. Allen, J. Cichy, T. M. Handel, and E. C. Butcher Chemerin Activation by Serine Proteases of the Coagulation, Fibrinolytic, and Inflammatory Cascades J. Biol. Chem., October 14, 2005; 280(41): 34661 - 34666. [Abstract] [Full Text] [PDF]

				M. Del Corno, M. C. Gauzzi, G. Penna, F. Belardelli, L. Adorini, and S. Gessani Human Immunodeficiency Virus Type 1 gp120 and Other Activation Stimuli Are Highly Effective in Triggering Alpha Interferon and CC Chemokine Production in Circulating Plasmacytoid but Not Myeloid Dendritic Cells J. Virol., October 1, 2005; 79(19): 12597 - 12601. [Abstract] [Full Text] [PDF]

				D. A. Hesselink, M. G. H. Betjes, M. A. Verkade, P. Athanassopoulos, C. C. Baan, and W. Weimar The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells Nephrol. Dial. Transplant., September 1, 2005; 20(9): 1868 - 1873. [Abstract] [Full Text] [PDF]

				M. Urosevic, R. Dummer, C. Conrad, M. Beyeler, E. Laine, G. Burg, and M. Gilliet Disease-Independent Skin Recruitment and Activation of Plasmacytoid Predendritic Cells Following Imiquimod Treatment J Natl Cancer Inst, August 3, 2005; 97(15): 1143 - 1153. [Abstract] [Full Text] [PDF]

				J. C. Salazar, C. D. Pope, M. W. Moore, J. Pope, T. G. Kiely, and J. D. Radolf Lipoprotein-Dependent and -Independent Immune Responses to Spirochetal Infection Clin. Vaccine Immunol., August 1, 2005; 12(8): 949 - 958. [Abstract] [Full Text] [PDF]

				C. Asselin-Paturel, G. Brizard, K. Chemin, A. Boonstra, A. O'Garra, A. Vicari, and G. Trinchieri Type I interferon dependence of plasmacytoid dendritic cell activation and migration J. Exp. Med., April 4, 2005; 201(7): 1157 - 1167. [Abstract] [Full Text] [PDF]

				G.-X. Yang, Z.-X. Lian, K. Kikuchi, Y.-J. Liu, A. A. Ansari, S. Ikehara, and M. E. Gershwin CD4- Plasmacytoid Dendritic Cells (pDCs) Migrate in Lymph Nodes by CpG Inoculation and Represent a Potent Functional Subset of pDCs J. Immunol., March 15, 2005; 174(6): 3197 - 3203. [Abstract] [Full Text] [PDF]

				W. Vermi, E. Riboldi, V. Wittamer, F. Gentili, W. Luini, S. Marrelli, A. Vecchi, J.-D. Franssen, D. Communi, L. Massardi, et al. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin J. Exp. Med., February 22, 2005; 201(4): 509 - 515. [Abstract] [Full Text] [PDF]

				H. Hashizume, T. Horibe, H. Yagi, N. Seo, and M. Takigawa Compartmental Imbalance and Aberrant Immune Function of Blood CD123+ (Plasmacytoid) and CD11c+ (Myeloid) Dendritic Cells in Atopic Dermatitis J. Immunol., February 15, 2005; 174(4): 2396 - 2403. [Abstract] [Full Text] [PDF]

				K. McKenna, A.-S. Beignon, and N. Bhardwaj Plasmacytoid Dendritic Cells: Linking Innate and Adaptive Immunity J. Virol., January 1, 2005; 79(1): 17 - 27. [Full Text] [PDF]

				B. A. Zabel, A. M. Silverio, and E. C. Butcher Chemokine-Like Receptor 1 Expression and Chemerin-Directed Chemotaxis Distinguish Plasmacytoid from Myeloid Dendritic Cells in Human Blood J. Immunol., January 1, 2005; 174(1): 244 - 251. [Abstract] [Full Text] [PDF]

				M. C. Gauzzi, C. Purificato, K. Donato, Y. Jin, L. Wang, K. C. Daniel, A. A. Maghazachi, F. Belardelli, L. Adorini, and S. Gessani Suppressive Effect of 1{alpha},25-Dihydroxyvitamin D3 on Type I IFN-Mediated Monocyte Differentiation into Dendritic Cells: Impairment of Functional Activities and Chemotaxis J. Immunol., January 1, 2005; 174(1): 270 - 276. [Abstract] [Full Text] [PDF]

				K. B. Gurney, A. D. Colantonio, B. Blom, H. Spits, and C. H. Uittenbogaart Endogenous IFN-{alpha} Production by Plasmacytoid Dendritic Cells Exerts an Antiviral Effect on Thymic HIV-1 Infection J. Immunol., December 15, 2004; 173(12): 7269 - 7276. [Abstract] [Full Text] [PDF]

				N. Kohrgruber, M. Groger, P. Meraner, E. Kriehuber, P. Petzelbauer, S. Brandt, G. Stingl, A. Rot, and D. Maurer Plasmacytoid Dendritic Cell Recruitment by Immobilized CXCR3 Ligands J. Immunol., December 1, 2004; 173(11): 6592 - 6602. [Abstract] [Full Text] [PDF]

				M. Vulcano, S. Dusi, D. Lissandrini, R. Badolato, P. Mazzi, E. Riboldi, E. Borroni, A. Calleri, M. Donini, A. Plebani, et al. Toll Receptor-Mediated Regulation of NADPH Oxidase in Human Dendritic Cells J. Immunol., November 1, 2004; 173(9): 5749 - 5756. [Abstract] [Full Text] [PDF]

				R. Lande, E. Giacomini, B. Serafini, B. Rosicarelli, G. D. Sebastiani, G. Minisola, U. Tarantino, V. Riccieri, G. Valesini, and E. M. Coccia Characterization and Recruitment of Plasmacytoid Dendritic Cells in Synovial Fluid and Tissue of Patients with Chronic Inflammatory Arthritis J. Immunol., August 15, 2004; 173(4): 2815 - 2824. [Abstract] [Full Text] [PDF]

				S. Pichyangkul, K. Yongvanitchit, U. Kum-arb, H. Hemmi, S. Akira, A. M. Krieg, D. G. Heppner, V. A. Stewart, H. Hasegawa, S. Looareesuwan, et al. Malaria Blood Stage Parasites Activate Human Plasmacytoid Dendritic Cells and Murine Dendritic Cells through a Toll-Like Receptor 9-Dependent Pathway J. Immunol., April 15, 2004; 172(8): 4926 - 4933. [Abstract] [Full Text] [PDF]

				C. H. Van Krinks, M. K. Matyszak, and J. S. Hill Gaston Characterization of plasmacytoid dendritic cells in inflammatory arthritis synovial fluid Rheumatology, April 1, 2004; 43(4): 453 - 460. [Abstract] [Full Text] [PDF]

				N. J. Megjugorac, H. A. Young, S. B. Amrute, S. L. Olshalsky, and P. Fitzgerald-Bocarsly Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells J. Leukoc. Biol., March 1, 2004; 75(3): 504 - 514. [Abstract] [Full Text] [PDF]

				M. Schnurr, T. Toy, A. Shin, G. Hartmann, S. Rothenfusser, J. Soellner, I. D. Davis, J. Cebon, and E. Maraskovsky Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells Blood, February 15, 2004; 103(4): 1391 - 1397. [Abstract] [Full Text] [PDF]

				B. L. Colvin, A. E. Morelli, A. J. Logar, A. H. Lau, and A. W. Thomson Comparative evaluation of CC chemokine-induced migration of murine CD8{alpha}+ and CD8{alpha}- dendritic cells and their in vivo trafficking J. Leukoc. Biol., February 1, 2004; 75(2): 275 - 285. [Abstract] [Full Text] [PDF]

				A. Kaser, S. Kaser, N. C. Kaneider, B. Enrich, C. J. Wiedermann, and H. Tilg Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression Blood, January 15, 2004; 103(2): 648 - 655. [Abstract] [Full Text] [PDF]

				S. Vitale, A. Schmid-Alliana, V. Breuil, M. Pomeranz, M.-A. Millet, B. Rossi, and H. Schmid-Antomarchi Soluble Fractalkine Prevents Monocyte Chemoattractant Protein-1-Induced Monocyte Migration via Inhibition of Stress-Activated Protein Kinase 2/p38 and Matrix Metalloproteinase Activities J. Immunol., January 1, 2004; 172(1): 585 - 592. [Abstract] [Full Text] [PDF]

				C. Asselin-Paturel, G. Brizard, J.-J. Pin, F. Briere, and G. Trinchieri Mouse Strain Differences in Plasmacytoid Dendritic Cell Frequency and Function Revealed by a Novel Monoclonal Antibody J. Immunol., December 15, 2003; 171(12): 6466 - 6477. [Abstract] [Full Text] [PDF]

				A. Izaguirre, B. J. Barnes, S. Amrute, W.-S. Yeow, N. Megjugorac, J. Dai, D. Feng, E. Chung, P. M. Pitha, and P. Fitzgerald-Bocarsly Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells J. Leukoc. Biol., December 1, 2003; 74(6): 1125 - 1138. [Abstract] [Full Text]

				S. Pichyangkul, T. P. Endy, S. Kalayanarooj, A. Nisalak, K. Yongvanitchit, S. Green, A. L. Rothman, F. A. Ennis, and D. H. Libraty A Blunted Blood Plasmacytoid Dendritic Cell Response to an Acute Systemic Viral Infection Is Associated with Increased Disease Severity J. Immunol., November 15, 2003; 171(10): 5571 - 5578. [Abstract] [Full Text] [PDF]

				E. Hartmann, B. Wollenberg, S. Rothenfusser, M. Wagner, D. Wellisch, B. Mack, T. Giese, O. Gires, S. Endres, and G. Hartmann Identification and Functional Analysis of Tumor-Infiltrating Plasmacytoid Dendritic Cells in Head and Neck Cancer Cancer Res., October 1, 2003; 63(19): 6478 - 6487. [Abstract] [Full Text] [PDF]

				B. Vanbervliet, N. Bendriss-Vermare, C. Massacrier, B. Homey, O. de Bouteiller, F. Briere, G. Trinchieri, and C. Caux The Inducible CXCR3 Ligands Control Plasmacytoid Dendritic Cell Responsiveness to the Constitutive Chemokine Stromal Cell-derived Factor 1 (SDF-1)/CXCL12 J. Exp. Med., September 2, 2003; 198(5): 823 - 830. [Abstract] [Full Text] [PDF]

				L. Lasagni, M. Francalanci, F. Annunziato, E. Lazzeri, S. Giannini, L. Cosmi, C. Sagrinati, B. Mazzinghi, C. Orlando, E. Maggi, et al. An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4 J. Exp. Med., June 2, 2003; 197(11): 1537 - 1549. [Abstract] [Full Text] [PDF]

				G. de la Rosa, N. Longo, J. L. Rodriguez-Fernandez, A. Puig-Kroger, A. Pineda, A. L. Corbi, and P. Sanchez-Mateos Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration J. Leukoc. Biol., May 1, 2003; 73(5): 639 - 649. [Abstract] [Full Text] [PDF]

				J.-F. Fonteneau, M. Gilliet, M. Larsson, I. Dasilva, C. Munz, Y.-J. Liu, and N. Bhardwaj Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity Blood, May 1, 2003; 101(9): 3520 - 3526. [Abstract] [Full Text] [PDF]

				V. Pullarkat, P. P. Lee, R. Scotland, V. Rubio, S. Groshen, C. Gee, R. Lau, J. Snively, S. Sian, S. L. Woulfe, et al. A Phase I Trial of SD-9427 (Progenipoietin) with a Multipeptide Vaccine for Resected Metastatic Melanoma Clin. Cancer Res., April 1, 2003; 9(4): 1301 - 1312. [Abstract] [Full Text] [PDF]

				M. Vulcano, S. Struyf, P. Scapini, M. Cassatella, S. Bernasconi, R. Bonecchi, A. Calleri, G. Penna, L. Adorini, W. Luini, et al. Unique Regulation of CCL18 Production by Maturing Dendritic Cells J. Immunol., April 1, 2003; 170(7): 3843 - 3849. [Abstract] [Full Text] [PDF]

				G. Penna, M. Vulcano, A. Roncari, F. Facchetti, S. Sozzani, and L. Adorini Cutting Edge: Differential Chemokine Production by Myeloid and Plasmacytoid Dendritic Cells J. Immunol., December 15, 2002; 169(12): 6673 - 6676. [Abstract] [Full Text] [PDF]

				P. Brawand, D. R. Fitzpatrick, B. W. Greenfield, K. Brasel, C. R. Maliszewski, and T. De Smedt Murine Plasmacytoid Pre-Dendritic Cells Generated from Flt3 Ligand-Supplemented Bone Marrow Cultures Are Immature APCs J. Immunol., December 15, 2002; 169(12): 6711 - 6719. [Abstract] [Full Text] [PDF]

				A. Krug, R. Uppaluri, F. Facchetti, B. G. Dorner, K. C. F. Sheehan, R. D. Schreiber, M. Cella, and M. Colonna Cutting Edge: IFN-Producing Cells Respond to CXCR3 Ligands in the Presence of CXCL12 and Secrete Inflammatory Chemokines upon Activation J. Immunol., December 1, 2002; 169(11): 6079 - 6083. [Abstract] [Full Text] [PDF]

				E. Scandella, Y. Men, S. Gillessen, R. Forster, and M. Groettrup Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells Blood, July 30, 2002; 100(4): 1354 - 1361. [Abstract] [Full Text] [PDF]

				T. Luft, M. Jefford, P. Luetjens, T. Toy, H. Hochrein, K.-A. Masterman, C. Maliszewski, K. Shortman, J. Cebon, and E. Maraskovsky Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets Blood, July 30, 2002; 100(4): 1362 - 1372. [Abstract] [Full Text] [PDF]

				T. Okada, V. N. Ngo, E. H. Ekland, R. Forster, M. Lipp, D. R. Littman, and J. G. Cyster Chemokine Requirements for B Cell Entry to Lymph Nodes and Peyer's Patches J. Exp. Med., July 1, 2002; 196(1): 65 - 75. [Abstract] [Full Text] [PDF]

				P. Romagnani, M. Rotondi, E. Lazzeri, L. Lasagni, M. Francalanci, A. Buonamano, S. Milani, P. Vitti, L. Chiovato, M. Tonacchera, et al. Expression of IP-10/CXCL10 and MIG/CXCL9 in the Thyroid and Increased Levels of IP-10/CXCL10 in the Serum of Patients with Recent-Onset Graves' Disease Am. J. Pathol., July 1, 2002; 161(1): 195 - 206. [Abstract] [Full Text] [PDF]

				J. H. Dufour, M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster IFN-{gamma}-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking J. Immunol., April 1, 2002; 168(7): 3195 - 3204. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Penna, G. Articles by Adorini, L. Search for Related Content PubMed PubMed Citation Articles by Penna, G. Articles by Adorini, L.